Related Experiment Video
Updated: May 27, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Targeting Raf/MEK/ERK pathway in pituitary adenomas
Zhang Suojun1, Wan Feng, Guo Dongsheng
1Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095#, Wuhan 430030, PR China.
European Journal of Cancer (Oxford, England : 1990)
|November 29, 2011
Summary
The Raf/MEK/ERK pathway is crucial in pituitary adenoma development. Targeting this signaling pathway offers potential new treatments for pituitary tumors.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Pituitary adenomas are common tumors causing mass effect and endocrine issues.
- Their development involves oncogene activation, tumor suppressor gene inactivation, and intracellular signaling anomalies.
- The Raf/MEK/ERK pathway is a central signaling cascade implicated in pituitary tumorigenesis.
Purpose of the Study:
- To review the role of the Raf/MEK/ERK signaling pathway in pituitary adenoma formation.
- To explore the therapeutic potential of targeting this pathway for pituitary adenoma treatment.
Main Methods:
- Literature review of studies on pituitary adenoma pathogenesis.
- Analysis of the involvement of the Raf/MEK/ERK pathway in cellular processes.
- Evaluation of clinical data regarding targeted therapies.
Main Results:
- The Raf/MEK/ERK pathway regulates cell growth, differentiation, and survival.
- Dysregulation of this pathway is linked to the development of pituitary adenomas and other cancers.
- The pathway's central role suggests its viability as a therapeutic target.
Conclusions:
- The Raf/MEK/ERK signaling pathway is significantly involved in pituitary tumor development.
- Targeting the Raf/MEK/ERK pathway presents a promising strategy for future pituitary adenoma therapies.
Related Concept Videos
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...